drugset

drugset / Trial / NCT00985738

Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer

NCT00985738 ↗

Phase 2 Terminated 16 enrolled University of Colorado, Denver GlaxoSmithKline · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of short-term intake of daily Dutasteride in patients with prostate cancer.

Timeline

Start: 2009-09
Primary completion: 2013-01
Completion: 2013-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dutasteride	Small molecule	0.5 mg	—

Indications